During the past decade, Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases" #1 collaborator was "Autoimmunity Centers of Excellence" with 1 trials as a collaborator and "Rho Federal Systems Division, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases" are "Juvenile Dermatomyositis (JDM)" (1 trials), "Juvenile Idiopathic Arthritis (JIA)" (1 trials), "Multiple Sclerosis (MS)" (1 trials), "Pediatric SLE" (1 trials) and "Pediatric-Onset Multiple Sclerosis (POMS)" (1 trials). Many other conditions were trialed in "Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases" in a lesser frequency.

Most popular intervention types in "Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ad26.COV2.S" (1 trials), "BNT162b2" (1 trials), "BNT162b2, Bivalent" (1 trials), "Continue IS (B cell depletion therapy)" (1 trials) and "Continue IS (MMF or MPA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".